Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients

Published:2019-02 Issue: Volume:108 Page:61-68
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ben-Betzalel Guy,Steinberg-Silman Yael,Stoff Ronen,Asher Nethanel^ORCID,Shapira-Frommer Ronnie,Schachter Jacob,Markel Gal

Funder

MSD

Roche

BMS

Novartis

Biond Biologics

FameWave

4C BioMed

AstraZeneca

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

2. KEYNOTE-006 investigators pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

3. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006);Schachter;Lancet Lond. Engl.,2017

4. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients;Balch;Ann Surg Oncol,2014

5. Age as a prognostic factor in patients with localized melanoma and regional metastases;Balch;Ann Surg Oncol,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

2. Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting;Melanoma Research;2024-08-30

3. Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients;American Journal of Clinical Oncology;2024-06-28

4. A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy;Cell Host & Microbe;2024-04

5. Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective;Cancers;2023-12-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3